Beck Automation Expands Into the Medical Market

Beck Automation (Swiss based) develops innovative automation solutions that can be integrated into the production processes of plastics processing industries. The company, which is now in its third generation of family management, has now established another mainstay in the medical sector. The focus is on producers of medical consumables that are manufactured using injection moulding. The first projects have already been realized.

“We have been looking at this option for about four years, as Switzerland is a global medical location with pharmaceutical companies and research and development facilities. Furthermore, we see an increasing demand for automation solutions, which we can serve with our profound automation know-how and our many years of experience regarding the development and production of customized solutions. Therefore, our entry into the medical market is therefore a consistent step. At the same time, it represents a milestone in the history of Beck Automation”, explains Nicolas Beck, managing owner of Beck Automation AG, the step into the medical sector. A separate business unit was founded within the company for this purpose. “We want to focus specifically on the medical market. For this reason, the medical business unit will operate autonomously within our organization in order to be able to react competently, flexibly, and quickly to customer requirements,” adds Nino Zehnder, Marketing and Sales Manager at Beck Automation.

Already in the planning phase of the new business unit, a start was made on building up product- and market-specific knowledge as well as personnel. Engineering, project management, and service were aligned according to the new, specific conditions.

Ralf Ziemer completes the team in sales with his profound industry know-how. “There are many automation possibilities in the medical and cosmetics industry. Beck has 36 years of experience in the field of automation. Because of this, our products are very interesting for pharmaceutical companies, their manufacturers, but also for companies in the cosmetics industry. We offer excellent solution possibilities,” says Ziemer.

Beck is aware that medical components are not standard parts. The products require very individual, customized solutions and this is where the company sees its core competence. “Our customers benefit from our highly efficient, customized systems that offer sustainable economic advantages. We set ourselves the highest standards in product and production reliability. We ensure this through solutions that are reproducible, validatable and hygienically flawless,” Zehnder continues.

Medical products must not pose any risks to patients and users, which is why they must be free of defects. “Our systems rule out mismanipulation, are modular in design, and can be realized in a small space. Cost pressure is constantly increasing, and production space, especially in cleanrooms, is expensive. We have to take this into account,” adds Ziemer.  Beck’s solutions comply with the regulations of Good Manufacturing Practice (GMP) and the U.S. Food and Drug Administration (FDA) and are suitable for cleanrooms up to class ISO 8.

 

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”